- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03990012
Infrared Imaging for Breast Cancer Modeling
The primary objective of this study is to obtain infrared (IR) images and video and three-dimensional (3-D) scans of patients referred for biopsy based on the results of their diagnostic breast exam(s).
This research study is investigating infrared imaging (also referred to as infrared thermography, or digital infrared thermal imaging (DITI)) of breast cancer. The infrared images collected in this study will be used to construct a computational biothermal engineering model of the cancerous breast.
Patients will undergo standard breast cancer screening procedures as part of routine care at Parkland Comprehensive Breast Center. For any patients who are referred for biopsy based on the results of their breast cancer screening procedures, this research study will take infrared images of the patient. Patients will undergo infrared imaging prior to biopsy but will not delay biopsy or treatment; infrared images & video may be recorded at biopsy visit. The biopsy will confirm/diagnose whether the patient has a benign or malignant condition.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The purpose of this research study is to obtain IR images, IR video, and 3-D scans of female patients' breasts (i.e., thermograms) who have been referred for biopsy based on the results of their diagnostic breast exams. These patients may be later diagnosed with a malignant or benign breast condition. The infrared images and video collected will be used to construct and validate a computational biothermal engineering model of breast cancer.
This research study does not involve any investigational drugs or treatments. This research study does not involve any FDA-approved drugs or devices.
In this research study, the equipment used (IR camera, 3-D scanner) will no be tested nor be used to diagnose or treat. Further, medical decisions will not be based on the use of these devices.
Infrared imaging (or digital thermal infrared imaging, DITI) is a non-invasive, non-contact, and harmless imaging procedure that measures the natural infrared radiation (body heat) emitted by the human body at normal 37°C body temperature. This procedure does not expose the patient to any radiation and is therefore entirely safe for the patient.
IR images and video will be obtained by IR equipment provided by University of Texas (UT) at Dallas researchers. IR equipment consists of an IR camera and ancillary equipment (e.g., tripod, computer, and vendor-provided IR image-processing software). The IR camera that will be used will be a commercial off-the-shelf product.
Additionally, a 3-D scanner will be used to obtain a 3-D surface contour map of the patient's breasts. This 3-D scanner is also non-invasive, non-contact, and does not expose the patient any radiation, similar to the IR camera. The 3-D scanner outputs a file format that is compatible with 3-D computer-aided design (CAD) software for engineering analysis.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Texas
-
Dallas, Texas, Förenta staterna, 75235
- Parkland Memorial Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Females with a suspicious breast mass (BI-RADS 4C or 5).
- Referred for a breast biopsy.
- Capable of providing informed consent.
Exclusion Criteria:
- Currently undergoing treatment for breast cancer.
- Incapable of providing informed consent.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Diagnostisk
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Patients referred for breast biopsy
Patients with Breast Imaging-Reporting and Data System (BI-RADS) 4C or 5 diagnosis who have been referred for breast biopsy based on the results of their standard diagnostic breast exam will undergo IR and 3D imaging of the breasts.
|
Subjects will undergo steady steady state and video IR imaging of the breasts.
Subjects will undergo 3D scanning of the breasts.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Spatial location of breast tumors
Tidsram: Two years
|
Researchers will use subjects' radiological imaging data to quantify the location of the tumor inside the breast, including mammography, ultrasound, and/or magnetic resonance imaging (MRI), for patients who are diagnosed with breast cancer.
The tumor location will be measured.
The tumor location will serve as an input for the computational model.
No diagnostic assessments will be made from these data for this research study.
|
Two years
|
|
3-D Surface contour maps of the breast
Tidsram: Two years
|
Researchers will use a 3-D scanning device to reconstruct the 3-D surface geometry of subjects' breasts.
The surface geometry of subjects' breasts will be measured.
The surface geometry will serve as an input for the computational model.
No diagnostic assessments will be made from these data for this research study.
|
Two years
|
|
Computational thermal model of breast cancer
Tidsram: Two years
|
Researchers will use study data to validate a computational biothermal engineering model of the cancerous breast.
The computational model will model and simulate the internal thermodynamic and heat transfer processes inside the breast with cancer.
The model outputs expected surface temperatures of the breast with cancer.
The model will be constructed using commercial engineering software, ANSYS Fluent.
No diagnostic assessments will be made from these data for this research study.
|
Two years
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Jody Hayes, MD, UT Southwestern Medical Center
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- STU-2018-0370
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Bröstcancer
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital och andra samarbetspartnersAvslutadDen kliniska tillämpningsguiden för Conebeam Breast CTKina
-
ETOP IBCSG Partners FoundationAvslutadBreast Cancer Invasive NosItalien
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; Roche Farma, S.AAvslutadBreast Cancer Invasive NosSpanien
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional...OkändBRCA1-mutation | Breast Cancer Invasive NosPolen
-
Novartis PharmaceuticalsAvslutadMetastaserad bröstcancer (MBC) | Locally Advance Breast Cancer (LABC)Storbritannien, Spanien
-
Cancer Institute and Hospital, Chinese Academy...RekryteringHER2-Low Unrecectable/Metastatic Breast Cancer Complicated with Visceral CrisisKina
-
University Health Network, TorontoAvslutadBreast Cancer Invasive Nos | Primär invasiv bröstcancerKanada
-
McMaster UniversityCanadian Breast Cancer FoundationAvslutadBreast Cancer Invasive Nos | Steg 0 BröstkarcinomKanada
Kliniska prövningar på IR Imaging
-
Bioxodes S.A.Avslutad
-
Bioxodes S.A.Aktiv, inte rekryterande
-
IR Technology, LLCAvslutadMuskuloskeletal smärta | Nociceptiv smärtaFörenta staterna
-
Institut Pasteur de LilleLuxomedAvslutadBedöm effekten av en IR-zonterapi på överviktiga och överviktiga personer i klass IFrankrike
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)AvslutadMelanom | Småcellig lungcancer | Kolorektala neoplasmer | Ovariella neoplasmer | LiposarkomFörenta staterna
-
Stallergenes GreerAvslutadRhinit, Allergisk, Perenn | HusdammskvalsterallergiFrankrike, Förenta staterna
-
Cerevel Therapeutics, LLCRekrytering
-
The University of Texas Medical Branch, GalvestonAvslutadInsulinresistens, diabetesFörenta staterna
-
F2G Biotech GmbHQuotient ClinicalAvslutad
-
University of RochesterNational Institute of Nursing Research (NINR); Stanford UniversityAvslutadHälsosamt åldrande | Lätt kognitiv funktionsnedsättningFörenta staterna